fbpx

To sign up for news and updates straight to your inbox, click here.

Wrapping up the 2018 state legislative session

U.S. Pain Foundation tracked nearly 900 bills relating to patient access and safety issues at the state level this session. Those priority issues, which included medical cannabis, integrative pain care, and access to innovative therapy options, yielded 150 bills that...

read more

The federal government wants to hear from pain patients

Opportunities for people with pain to have their voices heard by federal officials are rare. That’s why it’s so important for the public to take advantage of two major opportunities to comment on the state of pain care at the highest levels of the U.S. government: the...

read more

Advocates rally in Connecticut and Illinois for patient safety

Milestone events took place on April 3 and 11 as U.S. Pain Foundation hosted a legislative breakfast and two advocacy days, a first for the organization, which previously has hosted them only in collaboration with allied partners. The focus of both days was bills that...

read more

Congress hard at work on major new opioid-related legislation

This is an extremely busy time on Capitol Hill for legislation aimed at reducing opioid abuse and addiction. No less than four key committees with jurisdiction over health policy- Senate Health, Education, Labor and Pensions (HELP), Senate Finance, House Energy and...

read more

Migraine and headache patients: your action is needed

National Migraine & Headache Awareness Month (MHAM) this June is rapidly approaching! U.S. Pain is offering three fun, easy ways to get involved and help create awareness: Requesting a proclamation from your town or state Requesting a landmark or building in your...

read more

High-level pain management task force accepting public comment

The Pain Management Best Practices Inter-Agency Task Force is a new, high-level federal think-tank consisting of 28 appointees, including Cindy Steinberg, National Director of Policy and Advocacy for U.S. Pain Foundation. Overseen by the U.S. Department of Health and...

read more

Still time to take action to increase federal pain spending

A record 540 U.S. Pain members have sent 2,010 letters to their representatives through an online campaign to support the Opioids and STOP Pain Initiative Act. The bill would allocate $5 billion over 5 years toward developing new treatments for both chronic pain and...

read more

U.S. Pain outlines recommendations for CMS

U.S. Pain’s National Director of Policy and Advocacy, Cindy Steinberg, is constantly fighting behind-the-scenes for improvements in pain care. One recent example: last week she and the Academy of Integrative Pain Management issued two joint letters--one to the U.S....

read more

Advocate for medical cannabis in your state with a few clicks

U.S. Pain is offering three online letter-writing campaigns to urge legislators improve access to medical cannabis. Check below to see if your state is among those that don’t allow full access to medical cannabis for people with pain. Please note you may need to use...

read more

Take action now to fight for medical cannabis access

Despite recent roadblocks, including Attorney General Jeff Sessions’ efforts to restrict recreational marijuana use and the Veteran Administration's refusal to study cannabis’s therapeutic benefit, legislation at the state and federal level is moving forward to allow...

read more

Help support a landmark pain research funding bill

Pain advocates are encouraged to ask Congress to support Opioids and STOP Pain Initiative Act, which was introduced in December, through an easy online engagement campaign. HR4733/S2260 proposes to expand, intensify, and coordinate research at the National Institutes...

read more

U.S. Pain testifies on key bills in MA

Cindy Steinberg, U.S. Pain’s national director of policy and advocacy, testified twice at the Massachusetts State House in recent weeks on important pain policy legislation. On Dec. 19, she testified in support of a bill to ensure pain is properly assessed and managed...

read more

Director of NIH speaks at top pain policy meeting

The Interagency Pain Research Coordinating Committee (IPRCC), the nation’s highest pain policy advisory committee, held its biannual meeting Oct. 23 at the National Institutes of Health (NIH) campus in Bethesda, MD.  The IPRCC is the committee that oversaw the...

read more
New York adds protections for patients on biologics

New York adds protections for patients on biologics

After a two-year process calling on New York State lawmakers to update patient protections surrounding biologic treatments, U.S. Pain Foundation is pleased to announce that Gov. Andrew Cuomo signed a biologic substitution bill, Chapter 357 of the Laws of 2017. Earlier...

read more
Understanding the new CVS opioid policy

Understanding the new CVS opioid policy

Many in the chronic pain community expressed concern after CVS pharmacy announced this month that it will limit opioid prescriptions to seven days for acute or new conditions. The wording of the new policy is as follows: “This program will include limiting to seven...

read more
Illinois governor signs network transparency bill into law

Illinois governor signs network transparency bill into law

Ensuring network adequacy, transparency and uninterrupted service are all components of legislation recently signed into law by Illinois Gov. Bruce Rauner. An important patient protection measure initiated by the Illinois State Medical Society (ISMS) and supported by...

read more
Take action to help patients affected by Hurricane Harvey

Take action to help patients affected by Hurricane Harvey

As Texas and Louisiana continue efforts to keep residents safe, patient-centered organizations are concerned for pain patients and others who have had their treatments interrupted or are without medical equipment.To ensure patients affected by Hurricane Harvey  do not...

read more

U.S. Pain Advocacy Network revitalizes national coalition

In a conference room overlooking Washington, D.C., nonprofit organizations and other stakeholders gathered around the table and gave U.S. Pain Foundation the opportunity to present ideas and cultivate conversations surrounding patient access issues. Known as the...

read more

State advocacy update: biologics & interchangeable biosimilars

[su_pullquote align="right"]Terms to know: Biologic—Made from living organisms and manufactured through biotechnology, these medications are among those used to treat conditions such as rheumatoid arthritis, psoriasis and various forms of cancer. Biosimilar—A type of...

read more